3D Biotek, LLC

3D Biotek, LLC is a biomedical engineering firm based in New Jersey, USA, specializing in advanced technologies for the development of three-dimensional (3D) cell culture devices. The company utilizes its proprietary Precision 3D Micro-Fabrication Technology and Advanced Bio-Manufacturing Technology to lead the industry in research and development focused on applications in stem cell and tissue engineering, drug discovery, and various cell biology fields. 3D Biotek offers a range of high-quality 3D cell culture products and also provides customized solutions tailored to meet specific client requirements. One of their key innovations is the 3D Cell Expansion System (3D-CES), which is designed for the large-scale expansion of anchorage-dependent cells within a 3D micro-environment. In their laboratory, 3D Biotek has successfully expanded Adipose-Derived Stem Cells (ASCs) and Primary Human Fibroblasts (hFbs) to quantities of 200-300 million cells in approximately two weeks. The system features a two-chamber design that can accommodate up to 500 million cells per production cycle. This fully automated system is expected to be available in the market in the third quarter of 2024. 3D Biotek is also involved in initiatives to establish standards and measurements for tissue engineering scaffolds, as evidenced by their participation in workshops and publications. Their research includes innovative approaches to cancer tissue engineering, such as the development of a 3D polystyrene scaffold for isolating and amplifying lymphoma cancer cells from mixed cell populations. The company aims to replicate in vivo cell growth and behavior characteristics through its technology, contributing to the advancement of 3D cell culture methodologies. 3D Biotek is recognized as a US FDA registered and ISO-13485-2016 certified organization.

Driving directions from: